Cargando…

Detrimental and synergistic role of epilepsy – Alzheimer’s disease risk factors

Detalles Bibliográficos
Autores principales:	Filippov, Mikhail A., Vorobyov, Vasily V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524520/ https://www.ncbi.nlm.nih.gov/pubmed/30964059 http://dx.doi.org/10.4103/1673-5374.253519

Ejemplares similares

The brain compensatory mechanisms and Alzheimer's disease progression: a new protective strategy
por: Bobkova, Natalia, et al.
Publicado: (2015)

Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells
por: Nekrasov, Pavel V., et al.
Publicado: (2018)

Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer’s Disease
por: Kirchner, Kevin, et al.
Publicado: (2023)

Intracerebral interplay and neurotransmitter systems involvement in animal models of neurodegenerative disorders: EEG approach expectations
por: Vorobyov, Vasily, et al.
Publicado: (2017)

The Chernobyl Nuclear Catastrophe: Unacknowledged Health Detriment
por: Nussbaum, Rudi H.
Publicado: (2007)

Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls
por: Filippov, Mikhail A., et al.
Publicado: (2020)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

The Complex Intersection of Race and Rurality: The Detrimental Effects of Race-Neutral Rural Health Policies
por: Grundy, Stacy, et al.
Publicado: (2022)

Probiotics, prebiotics and their role in Alzheimer’s disease
por: D'Argenio, Valeria, et al.
Publicado: (2021)

Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome
por: Barone, Eugenio
Publicado: (2021)

Toward common mechanisms for risk factors in Alzheimer's syndrome
por: Medina, Miguel, et al.
Publicado: (2017)

The Role of Long Noncoding RNAs in Diabetic Alzheimer’s Disease
por: Kim, Young-Kook, et al.
Publicado: (2018)

Ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease
por: Fessel, Jeffrey
Publicado: (2019)

Hypoxia in Alzheimer’s disease: effects of hypoxia inducible factors
por: Hassan, Halimatu, et al.
Publicado: (2020)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Role of presynaptic calcium stores for neural network dysfunction in Alzheimer's disease
por: Lerdkrai, Chommanad, et al.
Publicado: (2018)

Recent advances on the role of long non-coding RNAs in Alzheimer's disease
por: Doxtater, Kyle, et al.
Publicado: (2020)

Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
por: Di Ciaula, Agostino, et al.
Publicado: (2022)

Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
por: Abate, Giulia, et al.
Publicado: (2020)

BACE1 role in Alzheimer's disease and other dementias: from the theory to the practice
por: Cervellati, Carlo, et al.
Publicado: (2021)

If ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease, then increasing TGFBR2 might be therapeutic
por: Fessel, Jeffrey
Publicado: (2020)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
por: Lopez Lopez, Cristina, et al.
Publicado: (2019)

Putative roles of cathepsin B in Alzheimer's disease pathology: the good, the bad, and the ugly in one?
por: Bernstein, Hans-Gert, et al.
Publicado: (2018)

Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease
por: Kelley, Sara, et al.
Publicado: (2022)

Neuroimaging in Pediatric Epilepsy
por: Shaikh, Zakir, et al.
Publicado: (2019)

A synergistic future for AI and ecology
por: Han, Barbara A., et al.
Publicado: (2023)

Endocannabinoid metabolism and Alzheimer's disease
por: Chen, Chu
Publicado: (2022)

OxInflammation in Alzheimer’s disease
por: Cervellati, Carlo, et al.
Publicado: (2023)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank
por: Vitek, Michael P., et al.
Publicado: (2021)

Vitamin A supplementation policy: A shift from universal to geographical targeted approach in India considered detrimental to health and nutritional status of under 5 years children
por: Arlappa, Nimmathota
Publicado: (2022)

The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?
por: Wu, Ye-Shun, et al.
Publicado: (2018)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

New Approaches to Treating Alzheimer’s Disease
por: Zheng, Hailin, et al.
Publicado: (2015)

The pathway to secondary prevention of Alzheimer's disease
por: McDade, Eric, et al.
Publicado: (2020)

Alzheimer’s Disease is a Disorder of Consciousness
por: Yokoi, Teruo
Publicado: (2023)

Open drug discovery in Alzheimer's disease
por: Axtman, Alison D., et al.
Publicado: (2023)

Reevaluating the cause of laminopathy in Alzheimer’s disease
por: Islam, Md Imamul, et al.
Publicado: (2023)

Unearthing the mechanisms of responsive neurostimulation for epilepsy
por: Rao, Vikram R., et al.
Publicado: (2023)

The Role of Fructose as a Cardiovascular Risk Factor: An Update
por: Busnatu, Stefan-Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tmq1kb5s0lgtorofrhfefpbfh0